Log in

Crispr Therapeutics Earnings Date, Estimates & History (NASDAQ:CRSP)

-2.07 (-3.98 %)
(As of 02/26/2020 08:38 AM ET)
Today's Range
Now: $49.89
50-Day Range
MA: $56.02
52-Week Range
Now: $49.89
Volume992,608 shs
Average Volume1.10 million shs
Market Capitalization$3.04 billion
P/E Ratio51.43
Dividend YieldN/A


Crispr Therapeutics (NASDAQ:CRSP) Earnings Information

Crispr Therapeutics last announced its earnings data on February 12th, 2020. The reported $0.51 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.68) by $1.19. The business had revenue of $77 million for the quarter, compared to analysts' expectations of $39.08 million. Its revenue was up 76900.0% compared to the same quarter last year. Crispr Therapeutics has generated $1.17 earnings per share over the last year and currently has a price-to-earnings ratio of 51.4. Crispr Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 4th, 2020 based off prior year's report dates.

Crispr Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Crispr Therapeutics (NASDAQ:CRSP) Earnings Estimates

2020 EPS Consensus Estimate: ($4.64)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($1.20)($1.00)($1.09)
Q2 20203($1.30)($1.07)($1.15)
Q3 20203($1.39)($1.01)($1.19)
Q4 20203($1.49)($1.02)($1.22)
Q1 20211($1.65)($1.65)($1.65)
Q2 20211($1.81)($1.81)($1.81)
Q3 20211($1.88)($1.88)($1.88)

Crispr Therapeutics (NASDAQ CRSP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
2/12/2020Q4 2019($0.68)$0.51$0.51$39.08 million$77.00 millionN/A
10/28/2019Q3($0.9480)$2.40$2.40$6.32 million$211.93 millionN/A
7/29/2019Q2($0.17)($1.01)($1.01)$47.57 million$0.32 millionN/A
4/29/2019Q1($0.90)($0.93)($0.93)$1.50 million$0.30 millionN/A
2/25/2019Q4 2018($0.83)($0.92)($0.92)$1.56 million$0.10 millionN/A
11/8/2018Q3($0.74)($1.07)($1.07)$2.64 million$0.56 millionN/A
8/8/2018Q2($0.6310)($0.82)($0.82)$1.47 million$1.09 millionN/A
5/9/20183/31/2018($0.67)($0.62)($0.62)$3.64 million$1.36 millionN/A
11/8/2017Q3($0.60)($0.62)($0.62)$3.61 million$2.39 millionN/A
8/10/20176/30/2017($0.62)($0.56)($0.56)$3.29 million$3.60 millionN/A
5/11/20173/31/2017($0.60)($0.54)($0.54)$2.70 millionN/A
3/10/2017Q4 2016($0.38)($0.40)($1.20)$2.34 millionN/A
11/22/2016Q3 2016($2.77)($2.77)$1.55 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel